Appeals court denies Trump request to delay trial in hush money case

by | Apr 8, 2024

A New York appeals court on Monday denied President Trump's request to postpone his trial in Manhattan District Attorney Alvin Bragg's case against him.

Trump had requested the court to delay his trial scheduled for April 15 while seeking a change of venue in the case. However, the court denied this request, a week before jury selection is slated to begin.

Justice Lizbeth González of the state’s mid-level appeals court rendered her decision following an emergency hearing where Trump's legal team requested a postponement of the trial indefinitely while they pursued a change of venue. Trump sought an emergency stay, a legal injunction to halt the trial's commencement as scheduled.

Trump's lawyer, Emil Bove, contended that the presumptive Republican nominee is susceptible to “significant bias” as a defendant in predominantly Democratic Manhattan. Bove supported his argument by referencing defense surveys and a scrutiny of media portrayal, asserting that the upcoming jury selection, slated to commence the following Monday, would be incapable of proceeding impartially.

In a different appellate issue, Trump's legal team is contesting a gag order imposed on him in the case, which Merchan recently extended to forbid Trump from discussing the judge's family. The appeals court indicated it would address this issue at a later time.

Documentation pertaining to Trump's appeals was sealed and not accessible to the public.

Source: AP News

 

 

Share this

Top News

Appeals court rules Trump may sue niece over NYT article

Appeals court rules Trump may sue niece over NYT article

A New York state appeals court has ruled that President Trump is entitled to pursue legal action against his niece, Mary Trump, for providing the New York Times with information that contributed to its 2018 investigation into his taxes and financial practices. The...

U.S. nearing deal to fund bird flu vaccine trial

U.S. nearing deal to fund bird flu vaccine trial

The U.S. government is on the verge of finalizing a deal to fund a late-stage trial of Moderna's mRNA-based bird flu vaccine, aiming to enhance its pandemic vaccine reserves as the H5N1 outbreak continues to impact egg farms and cattle herds. Sources familiar with the...